Skip to content

PGFS++: Molecular Property Improvement under Synthesis and Diversity Constraints

Aug 2026 · 0 citations · 23 references
Computer Science

TL;DR

PGFS++ is introduced, a synthesis-aware reinforcement learning framework for input-specific molecular improvement that improves target properties while preserving high output diversity, and experiments show that PGFS++ improves target properties while preserving high output diversity.

Abstract

Improving molecular properties, such as drug-likeness or binding affinity, is a recurring task in early-stage drug discovery. However, molecules optimized in an unconstrained chemical space have limited practical value if they cannot be synthesized. Policy Gradient for Forward Synthesis (PGFS) is a synthesis-aware reinforcement learning method for molecular improvement, but its use of reactant embedding prediction makes reactant selection indirect, which, as we show, limits learning effectiveness. We first develop PGFS+, in which reaction templates and second reactants are represented by trainable embedding lookup tables. Combined with a more effective scoring function and RL algorithm, PGFS+ significantly improves the desired property. However, it exposes a reward-hacking failure mode: a powerful reactant search can map diverse input molecules to the same high-reward magnet molecule, improving the reward while collapsing the output diversity. We therefore introduce PGFS++, a synthesis-aware reinforcement learning framework for input-specific molecular improvement. Given an input molecule, PGFS++ treats it as the start of a forward-synthesis trajectory, applies learned reaction templates with compatible in-stock building blocks, and produces a molecule with improved target properties, an explicit synthesis route, and structural similarity to the input. Experiments on molecular improvement tasks show that PGFS++ improves target properties while preserving high output diversity.

View source

Similar papers

Open access Jul 2026

PFM: perturbed flow matching for structure-based drug design

A novel method named Perturbed Flow Matching (PFM), which significantly reduces sampling steps by leveraging a Flow Matching framework and introduces a unique perturbed conditional probability path design that incorporates pocket binding site information and atom type-coordinate coupled information to enhance molecular...

Yankai Yu, Guikun Xu, Zhuyang Xie et al. · 0 citations
Open access Aug 2026

Generalizing molecular design via flexible search space control

ChemTSv3 is introduced, an exploration framework with a flexible architecture that accommodates diverse design scenarios for adaptive molecular design, and shows that this flexibility enables efficient exploration across diverse design spaces, from drug-like small molecules to proteins.

Satoru Fujii, Yuki Murakami, Tatsuya Yoshizawa et al. · 2 citations
Open access Aug 2026

PockLigGPT: Pocket-Sequence-Conditioned Molecular Generation with GPTs and RL

PockLigGPT achieves competitive docking-oriented performance under a standardized evaluation protocol while maintaining chemical plausibility, favorable physicochemical profiles, and Lipinski-based drug-likeness.

Pablo Varas Pardo, Guillermo Marcos-Ayuso, Eugenia Ulzurrun et al. · 0 citations
Jul 2026

Generating Developable 3D Molecules via Pocket-Conditioned Diffusion and Property-Aware Optimization

Drug discovery and development is time-consuming and resource-intensive, motivating computational approaches such as diffusion models for de novo drug design. Many such models follow the structure-based drug design (SBDD) paradigm, generating molecules to fit a target binding pocket. However, existing diffusion-based S...

Ruoxi Gao, Jiangweizhi Peng, Ziqi Chen et al. · 0 citations
Preprint Jul 2026

Sample Efficient Generative Optimization for Molecular Design

This work introduces Sample Efficient Generative Optimization (SEGO), a framework for Bayesian optimization on adaptively generated molecules, and attains state-of-the-art performance on the practical molecular optimization (PMO) benchmark using only one tenth of the oracle calls consumed by other methods.

S. Kopf, Cristina Nevado, P. Schwaller · 0 citations
Preprint Jul 2026

DrugGen 2: A disease-aware language model for enhancing drug discovery

By integrating disease-specific context into molecular generation, DrugGen-2 advances AI-assisted drug discovery, offering a powerful tool for de novo design and drug repurposing that accounts for the complex interplay between diseases and molecular targets.

Ali Motahharynia, Mohammadreza Ghaffarzadeh-Esfahani, Mahsa Sheikholeslami et al. · 0 citations

Related blog posts

MIT News · Artificial Intelligence Sep 29, 2026

Who we become when we talk to machines

Professor Sherry Turkle’s new book, “Artificial Intimacy,” offers a withering critique of chatbots and the antisocial dynamics she believes they encourage.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.